Subject(s)
Asymptomatic Infections , COVID-19/diagnostic imaging , Positron Emission Tomography Computed Tomography , Aged , COVID-19/diagnosis , COVID-19 Nucleic Acid Testing , Carcinoma/diagnostic imaging , Carcinoma/secondary , Fluorodeoxyglucose F18 , Follow-Up Studies , Humans , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/secondary , Lymph Nodes/diagnostic imaging , Male , Neoplasm Recurrence, Local/diagnostic imaging , Patient Compliance , Radiopharmaceuticals , Urinary Bladder Neoplasms/diagnostic imagingSubject(s)
COVID-19/diagnosis , Stevens-Johnson Syndrome/diagnosis , Adrenal Cortex Hormones/therapeutic use , Androstadienes/therapeutic use , Aromatase Inhibitors/therapeutic use , Body Surface Area , Bone Neoplasms/complications , Bone Neoplasms/drug therapy , Bone Neoplasms/secondary , Brain Neoplasms/complications , Brain Neoplasms/drug therapy , Brain Neoplasms/secondary , Breast Neoplasms/complications , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , COVID-19/complications , Dexamethasone/therapeutic use , Emollients/therapeutic use , Female , Hospitalization , Humans , Liver Neoplasms/complications , Liver Neoplasms/drug therapy , Liver Neoplasms/secondary , Middle Aged , Palliative Care , SARS-CoV-2 , Stevens-Johnson Syndrome/drug therapy , Stevens-Johnson Syndrome/etiology , Stevens-Johnson Syndrome/pathologyABSTRACT
In this review, we report a case of a bone's metastatic breast cancer in Malian patient treated by chemotherapy in whom SRAS-COV-2's diagnosis was made 9days after the onset gastrointestinal symptoms. Patient quickly died before any COVID-19's treatment. According to the poor outcomes of cancer patients with COVID-19, authors emphasize to an intensive attention to such patients in order to find the best therapeutic balance between the two pathologies during this pandemic.
Subject(s)
Betacoronavirus , Breast Neoplasms/complications , Carcinoma, Ductal, Breast/secondary , Coronavirus Infections/complications , Diarrhea/etiology , Pandemics , Pneumonia, Viral/complications , Spinal Neoplasms/secondary , Vomiting/etiology , Adult , Antineoplastic Agents, Phytogenic/therapeutic use , Bone Density Conservation Agents/therapeutic use , Breast Neoplasms/drug therapy , COVID-19 , Carcinoma, Ductal, Breast/complications , Carcinoma, Ductal, Breast/drug therapy , Docetaxel/therapeutic use , Fatal Outcome , Female , HIV Infections/complications , Humans , Liver Neoplasms/complications , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/drug therapy , Liver Neoplasms/secondary , SARS-CoV-2 , Spinal Neoplasms/complications , Spinal Neoplasms/diagnostic imaging , Spinal Neoplasms/drug therapy , Tomography, X-Ray Computed , Zoledronic Acid/therapeutic useABSTRACT
We report the case of who has been hospitalized complaining about fever in the last 4 days. Laboratory data revealed lymphocytopenia and leucopenia with an elevation of C-reactive protein and positive real-time reverse transcription-polymerase chain reaction (RT-PCR). Six days before this hospitalization, when the patient was asymptomatic, 18 F-FDG PET/CT images were performed for the therapeutic control of liver metastases of colorectal cancer. Lung abnormality findings at 18 F-FDG PET/CT images, unrelated to cancer metastases, but suspicious for viral infection, may suggest the presence of COVID-19 disease in its early phase before symptoms onset. Since PET/CT is more sensitive than CT scan in detecting host's reaction, the added value of this technique could be monitoring disease progression and could be used as a biomarker of lung disease activity and therefore as an important tool for a better understanding of the factors that contribute to the progression of lung disease.